|
[1]
|
{phenytoin, cerebral palsy}
|
→
|
{gingival hypertrophy}
|
0.000016
|
0.12
|
618.66
|
|
[2]
|
{carbamazepine, cerebral palsy}
|
→
|
{gingival hypertrophy}
|
0.000019
|
0.08
|
394.31
|
|
[3]
|
{clobazam, diazepam}
|
→
|
{gingival hypertrophy}
|
0.000016
|
0.07
|
377.71
|
|
[4]
|
{phenytoin, intellectual disability}
|
→
|
{gingival hypertrophy}
|
0.000021
|
0.07
|
375.08
|
|
[5]
|
{zonisamide, intellectual disability}
|
→
|
{gingival hypertrophy}
|
0.000014
|
0.05
|
256.30
|
|
[6]
|
{valproic acid, cerebral palsy}
|
→
|
{gingival hypertrophy}
|
0.000023
|
0.05
|
244.10
|
|
[7]
|
{epilepsy, cerebral palsy}
|
→
|
{gingival hypertrophy}
|
0.000028
|
0.05
|
233.00
|
|
[8]
|
{diazepam, phenytoin}
|
→
|
{gingival hypertrophy}
|
0.000019
|
0.04
|
206.07
|
|
[9]
|
{10–19 years of age, phenytoin}
|
→
|
{gingival hypertrophy}
|
0.000016
|
0.04
|
199.35
|
|
[10]
|
{phenobarbital, cerebral palsy}
|
→
|
{gingival hypertrophy}
|
0.000012
|
0.04
|
194.17
|
|
[11]
|
{zonisamide, phenobarbital}
|
→
|
{gingival hypertrophy}
|
0.000023
|
0.04
|
183.73
|
|
[12]
|
{<10 y.o., zonisamide}
|
→
|
{gingival hypertrophy}
|
0.000021
|
0.03
|
172.14
|
|
[13]
|
{clobazam, phenytoin}
|
→
|
{gingival hypertrophy}
|
0.000016
|
0.03
|
153.34
|
|
[14]
|
{valproic acid, intellectual disability}
|
→
|
{gingival hypertrophy}
|
0.000023
|
0.03
|
152.11
|
|
[15]
|
{carbamazepine, diazepam}
|
→
|
{gingival hypertrophy}
|
0.000021
|
0.03
|
142.39
|
|
[16]
|
{clobazam, phenobarbital}
|
→
|
{gingival hypertrophy}
|
0.000012
|
0.03
|
141.60
|
|
[17]
|
{diazepam, epilepsy}
|
→
|
{gingival hypertrophy}
|
0.000021
|
0.03
|
137.71
|
|
[18]
|
{epilepsy, intellectual disability}
|
→
|
{gingival hypertrophy}
|
0.000023
|
0.03
|
130.43
|
|
[19]
|
{valproic acid, phenytoin}
|
→
|
{gingival hypertrophy}
|
0.000044
|
0.02
|
125.83
|
|
[20]
|
{diazepam, valproic acid}
|
→
|
{gingival hypertrophy}
|
0.000023
|
0.02
|
123.52
|
|
[21]
|
{carbamazepine, phenytoin}
|
→
|
{gingival hypertrophy}
|
0.000030
|
0.02
|
119.21
|
|
[22]
|
{<10 y.o., phenobarbital}
|
→
|
{gingival hypertrophy}
|
0.000023
|
0.02
|
115.45
|
|
[23]
|
{clonazepam, phenytoin}
|
→
|
{gingival hypertrophy}
|
0.000012
|
0.02
|
114.93
|
|
[24]
|
{<10 y.o., clobazam}
|
→
|
{gingival hypertrophy}
|
0.000012
|
0.02
|
111.44
|
|
[25]
|
{<10 y.o., cerebral palsy}
|
→
|
{gingival hypertrophy}
|
0.000012
|
0.02
|
107.69
|
|
[26]
|
{clobazam, zonisamide}
|
→
|
{gingival hypertrophy}
|
0.000014
|
0.02
|
106.42
|
|
[27]
|
{carbamazepine, clobazam}
|
→
|
{gingival hypertrophy}
|
0.000014
|
0.02
|
97.02
|
|
[28]
|
{zonisamide, phenytoin}
|
→
|
{gingival hypertrophy}
|
0.000014
|
0.02
|
89.67
|
|
[29]
|
{epilepsy, phenytoin}
|
→
|
{gingival hypertrophy}
|
0.000044
|
0.02
|
85.21
|
|
[30]
|
{cerebral palsy}
|
→
|
{gingival hypertrophy}
|
0.000028
|
0.02
|
82.79
|
|
[31]
|
{carbamazepine, phenobarbital}
|
→
|
{gingival hypertrophy}
|
0.000014
|
0.02
|
79.89
|
|
[32]
|
{valproic acid, phenobarbital}
|
→
|
{gingival hypertrophy}
|
0.000023
|
0.02
|
78.38
|
|
[33]
|
{clobazam, valproic acid}
|
→
|
{gingival hypertrophy}
|
0.000019
|
0.01
|
76.22
|
|
[34]
|
{phenytoin, phenobarbital}
|
→
|
{gingival hypertrophy}
|
0.000016
|
0.01
|
75.70
|
|
[35]
|
{epilepsy, phenobarbital}
|
→
|
{gingival hypertrophy}
|
0.000023
|
0.01
|
73.54
|
|
[36]
|
{periodontitis}
|
→
|
{gingival hypertrophy}
|
0.000014
|
0.01
|
71.69
|
|
[37]
|
{zonisamide, valproic acid}
|
→
|
{gingival hypertrophy}
|
0.000023
|
0.01
|
70.41
|
|
[38]
|
{clobazam}
|
→
|
{gingival hypertrophy}
|
0.000026
|
0.01
|
62.79
|
|
[39]
|
{clobazam, epilepsy}
|
→
|
{gingival hypertrophy}
|
0.000014
|
0.01
|
61.88
|
|
[40]
|
{intellectual disability}
|
→
|
{gingival hypertrophy}
|
0.000023
|
0.01
|
60.38
|
|
[41]
|
{<10 y.o., epilepsy}
|
→
|
{gingival hypertrophy}
|
0.000019
|
0.01
|
59.78
|
|
[42]
|
{<10 y.o., valproic acid}
|
→
|
{gingival hypertrophy}
|
0.000019
|
0.01
|
58.17
|
|
[43]
|
{carbamazepine, valproic acid}
|
→
|
{gingival hypertrophy}
|
0.000028
|
0.01
|
55.27
|
|
[44]
|
{10–19 years of age, epilepsy}
|
→
|
{gingival hypertrophy}
|
0.000019
|
0.01
|
52.51
|
